The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells

Physiological Reports

Volumn 3, Issue 10, 2015, Pages

  Kalonji, Nadine Lusamba ^a   Nomura, Kazuhiro ^a   Kawase, Tetsuaki ^b   Ota, Chiharu ^a   Kubo, Hiroshi ^a   Sato, Takeya ^a   Yanagisawa, Teruyuki ^a   Sunazuka, Toshiaki ^c   Ömura, Satoshi ^c   Yamaya, Mutsuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Airway epithelial cell; COPD; EM900; Inflammation; Rhinovirus

Indexed keywords

CELL ADHESION MOLECULE; EM 900; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROLIDE; MESSENGER RNA; UNCLASSIFIED DRUG;

ACIDIFICATION; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CELL ADHESION; CELL DAMAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENDOSOME; HUMAN; HUMAN CELL; INFLAMMATION; NOSE MUCOSA; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RHINOVIRUS INFECTION; TRACHEA MUCOSA; VIRUS LOAD; VIRUS REPLICATION;

EID: 85005952357     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12557     Document Type: Article

References (26)

1. Abisheganaden, J. A., P. C. Avila, J. L. Kishiyama, J. Liu, S. Yagi, D. Schnurr, et al. 2000. Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, doubleblind, controlled trial. Am. J. Med. 108:453-459.
2. Albert, R. K., J. Connett, W. C. Bailey, R. Casaburi, J. A. Jr Cooper, G. J. Criner, et al., and COPD Clinical Research Network. 2011. Azithromycin for prevention of exacerbations of COPD. N. Engl. J. Med. 365:689-698.
3. Casasnovas, J. M., and T. A. Springer. 1994. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J. Virol. 68:5882-5889.
4. Greve, J. M., G. Davis, A. M. Meyer, C. P. Forte, S. C. Yost, C. W. Marlor, et al. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839-847.
5. Higashi, F, H. Kubo, H. Yasuda, T. Nukiwa, and M. Yamaya. 2014. Additional treatment with clarithromycin reduces fever duration in patients with influenza. Respir. Investig. 52:302-309.
6. Jang, Y. J., H. J. Kwon, and B. J. Lee. 2006. Effect of clarithromycin on rhinovirus-16 infection in A549 cells. Eur. Respir. J. 27:12-19.
7. Mellman, I., R. Fuchs, and A. Helenius. 1986. Acidification of the endocytic and exocytic pathways. Ann. Rev. Biochem. 55:663-700.
8. Nass, R., and R. Rao. 1998. Novel localization of a Na+/H+ exchanger in a late endosomal compartment of yeast. Implications for vacuole biogenesis. J. Biol. Chem. 273:21054-21060.
9. Ni, W., X. Shao, X. Cai, C. Wei, J. Cui, R. Wang, et al. 2015. Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis. PLoS ONE 10:e0121257.
10. Otsu, K., H. Ishinaga, S. Suzuki, A. Sugawara, T. Sunazuka, S. Omura, et al. 2011. Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line. Pharmacology 88:327-332.
11. Papi, A., and S. L. Johnston. 1999. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its upregulation by rhinovirus infection via NF-jB and GATA transcription factors. J. Biol. Chem. 274:30041-30051.
12. Perez, L., and L. Carrasco. 1993. Entry of poliovirus into cells does not require a low-pH step. J. Virol. 67:4543-4548.
13. Riise, G. C., S. Larsson, C. G. Lofdahl, and B. A. Andersson. 1994. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur. Respir. J. 7:1673-1677.
14. Seemungal, T. A., R. Harper-Owen, A. Bhowmik, D. J. Jeffries, and J. A. Wedzicha. 2000. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur. Respir. J. 16:677-683.
15. Seemungal, T. A., T. M. Wilkinson, J. R. Hurst, W. R. Perera, R. J. Sapsford, and J. A. Wedzicha. 2008. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am. J. Respir. Crit. Care Med. 178:1139-1147.
16. Sugawara, A., A. Sueki, T. Hirose, K. Nagai, H. Gouda, S. Hirono, et al. 2011. Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents. Bioorg. Med. Chem. Lett. 21:3373-3376.
17. Sugawara, A., A. Sueki, T. Hirose, H. Shima, K. S. Akagawa, S. Omura, et al. 2012. Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and/or immunomodulatory activity; synthesis, structure-activity relationships and in vivo study. J. Antibiot. (Tokyo) 65:487-490.
18. Suzuki, T., M. Yamaya, K. Sekizawa, M. Hosoda, N. Yamada, S. Ishizuka, et al. 2001a. Bafilomycin A1 inhibits rhinovirus infection in human airway epithelium: effects on endosome and ICAM-1. Am. J. Physiol. 280:L1115-L1127.
19. Suzuki, T., M. Yanai, M. Yamaya, T. Satoh-Nakagawa, K. Sekizawa, S. Ishida, et al. 2001b. Erythromycin and common cold in COPD. Chest 120:730-733.
20. Suzuki, T., M. Yamaya, K. Sekizawa, M. Hosoda, N. Yamada, S. Ishizuka, et al. 2002. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Respir. Crit. Care Med. 165:1113-1118.
21. Terao, H., K. Asano, K. Kanai, Y. Kyo, S. Watanabe, T. Hisamitsu, et al. 2003. Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators Inflamm. 12:195-202.
22. Yamaya, M., A. Azuma, H. Tanaka, H. Takizawa, K. Chida, Y. Taguchi, et al. 2008. Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysis. J. Am. Geriatr. Soc. 56:1358-1360.
23. Yamaya, M., A. Azuma, H. Takizawa, J. Kadota, J. Tamaoki, and S. Kudoh. 2012. Macrolide effects on the prevention of COPD exacerbations. Eur. Respir. J. 40:485-494.
24. Yamaya, M., L. K. Nadine, C. Ota, H. Kubo, T. Makiguchi, R. Nagatomi, et al. 2014a. Magnitude of influenza virus replication and cell damage is associated with interleukin-6 production in primary cultures of human tracheal epithelium. Respir. Physiol. Neurobiol. 202:16-23.
25. Yamaya, M., H. Nishimura, N. Lusamba, H. Kubo, and R. Nagatomi. 2014b. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells. Respir. Investig. 52:251-260.
26. Zhu, Z., W. Tang, A. Ray, Y. Wu, O. Einarsson, M. L. Landry, et al. 1996. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor jB-dependent transcriptional activation. J. Clin. Invest. 97:421-430.